138 related articles for article (PubMed ID: 27279639)
1. Targeted Silencing of S100A8 Gene by miR-24 to Increase Chemotherapy Sensitivity of Endometrial Carcinoma Cells to Paclitaxel.
Lang B; Shang C; Meng L
Med Sci Monit; 2016 Jun; 22():1953-8. PubMed ID: 27279639
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells.
Liu C; Xing G; Wu C; Zhu J; Wei M; Liu D; Ge Y; Chen Y; Lei T; Yang Y
Med Sci Monit; 2018 Mar; 24():1836-1846. PubMed ID: 29595187
[TBL] [Abstract][Full Text] [Related]
3. MiR-218 inhibits HMGB1-mediated autophagy in endometrial carcinoma cells during chemotherapy.
Ran X; Yang J; Liu C; Zhou P; Xiao L; Zhang K
Int J Clin Exp Pathol; 2015; 8(6):6617-26. PubMed ID: 26261543
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the potential theranostic role of KDM5B/miR-29c signaling axis in paclitaxel resistant endometrial carcinoma.
Li L; Shou H; Wang Q; Liu S
Gene; 2019 Apr; 694():76-82. PubMed ID: 30658067
[TBL] [Abstract][Full Text] [Related]
5. Mir-338-3p Inhibits Malignant Biological Behaviors of Glioma Cells by Targeting MACC1 Gene.
Shang C; Hong Y; Guo Y; Xue YX
Med Sci Monit; 2016 Mar; 22():710-6. PubMed ID: 26936749
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34a Attenuates Paclitaxel Resistance in Prostate Cancer Cells via Direct Suppression of JAG1/Notch1 Axis.
Liu X; Luo X; Wu Y; Xia D; Chen W; Fang Z; Deng J; Hao Y; Yang X; Zhang T; Zhou L; Wu Y; Wang Q; Xu J; Hu X; Li L
Cell Physiol Biochem; 2018; 50(1):261-276. PubMed ID: 30282072
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of miR-29a facilitates apoptosis of colorectal carcinoma cell SW480 and suppresses its Paclitaxel resistance.
Yuan LL; Li L; Liu JN; Mei J; Lei CJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5499-5507. PubMed ID: 30229821
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA tumor suppressor candidate 7 advances chemotherapy sensitivity of endometrial carcinoma through targeted silencing of miR-23b.
Shang C; Lang B; Ao CN; Meng L
Tumour Biol; 2017 Jun; 39(6):1010428317707883. PubMed ID: 28653877
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of miR-1271 inhibits endometrial cancer cells proliferation and induces cell apoptosis by targeting CDK1.
Li L; Qu YW; Li YP
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2816-2822. PubMed ID: 28682437
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
Huang X; Qin J; Lu S
Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-372 inhibits endometrial carcinoma development by targeting the expression of the Ras homolog gene family member C (RhoC).
Liu BL; Sun KX; Zong ZH; Chen S; Zhao Y
Oncotarget; 2016 Feb; 7(6):6649-64. PubMed ID: 26673619
[TBL] [Abstract][Full Text] [Related]
14. miR-101-3p induces autophagy in endometrial carcinoma cells by targeting EZH2.
Wang C; Liu B
Arch Gynecol Obstet; 2018 Jun; 297(6):1539-1548. PubMed ID: 29691644
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-182 promotes tumor cell growth by targeting transcription elongation factor A-like 7 in endometrial carcinoma.
Guo Y; Liao Y; Jia C; Ren J; Wang J; Li T
Cell Physiol Biochem; 2013; 32(3):581-90. PubMed ID: 24021963
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
[TBL] [Abstract][Full Text] [Related]
17. miR-15a-5p suppresses endometrial cancer cell growth via Wnt/β-catenin signaling pathway by inhibiting WNT3A.
Wang ZM; Wan XH; Sang GY; Zhao JD; Zhu QY; Wang DM
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):4810-4818. PubMed ID: 29164582
[TBL] [Abstract][Full Text] [Related]
18. miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.
Guo Y; Fu W; Chen H; Shang C; Zhong M
Oncol Rep; 2012 Apr; 27(4):1097-103. PubMed ID: 22139384
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-199a-3p regulates endometrial cancer cell proliferation by targeting mammalian target of rapamycin (mTOR).
Wu D; Huang HJ; He CN; Wang KY
Int J Gynecol Cancer; 2013 Sep; 23(7):1191-7. PubMed ID: 23851675
[TBL] [Abstract][Full Text] [Related]
20. The interactions between MicroRNA-200c and BRD7 in endometrial carcinoma.
Park YA; Lee JW; Choi JJ; Jeon HK; Cho Y; Choi C; Kim TJ; Lee NW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):125-33. PubMed ID: 22015043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]